removal of superficial foreign bodies from the ocular surface
and adnexa so long as treatment of diseases or conditions of
the visual system, other than glaucoma, dry eyes or
allergies, as authorized under this paragraph shall not
continue beyond six weeks from the initiation of treatment
unless the prescribing optometrist documents consultation
with a licensed physician. As used in this paragraph, the
initiation of treatment may, but need not, include the
prescription or administration of pharmaceutical agents for
therapeutic purposes.
[(3) The term shall not include:
(i) surgery, including, but not limited to, laser
surgery; the use of lasers for therapeutic purposes; and
the use of injections in the treatment of ocular disease;
(ii) the use of Schedule I and Schedule II
controlled substances;
(iii) treatment of systemic disease; and
(iv) the treatment of glaucoma, except that
optometrists may use all topical pharmaceutical agents in
the treatment of primary open angle glaucoma, exfoliation
glaucoma and pigmentary glaucoma.]
(4) The term shall not include:
(i) Surgery, including, but not limited to,
diagnostic, exploratory, palliative, therapeutic,
rehabilitative, cosmetic, reconstructive, refractive ,
light-based or laser surgery ; or the use of lasers for
therapeutic purposes .
(ii) Injections, other than the use of epinephrine
auto-injectors for anaphylaxis.
(iii) The use of Schedule I and Schedule II
A07134 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30